Target intelligence / Profile preview

P-glycoprotein (P-gp)

Target
P-gp
Molecular classification
Transmembrane glycoprotein, ATP-dependent efflux pump, ABC transporter
01

Overview

P-glycoprotein (P-gp) is a 170 kDa transmembrane glycoprotein that functions as an ATP-dependent efflux pump. It plays a crucial role in multidrug resistance and the transport of various substances across cell membranes. Structurally, it has two transmembrane domains and two nucleotide-binding domains that bind and hydrolyze ATP, connected by a flexible linker. Encoded by the MDR1 (ABCB1) gene, P-gp is widely distributed in tissues like the GI tract, blood-brain barrier, liver, and kidney, where it protects against xenobiotics, facilitates excretion, and restricts drug uptake into the brain. Its ability to transport a broad range of substrates with little specificity contributes significantly to multidrug resistance, drug bioavailability, and drug-drug interactions. P-gp's clinical significance is high, particularly in cancer resistance, pharmacokinetics, CNS drug delivery, and transplantation.

Other names
MDR1ABCB1
02

Mechanism of action

P-glycoprotein acts as an ATP-dependent efflux pump, actively transporting diverse substrates out of cells against concentration gradients using the energy from ATP hydrolysis.

03

Biological functions

ATP-dependent efflux pump activityTransport of substances across cell membranesProtection against xenobioticsExcretion of drugs and toxinsBlood-brain barrier protectionImmune system modulation
04

Disease associations

Multidrug resistance (MDR)Cancer (drug resistance)Pharmacokinetic modulationImpairment of CNS drug deliveryDrug-drug interactionsAllograft rejection
05

Safety considerations

Increased vulnerability to certain toxins (e.g., ivermectin) upon inhibitionAltered pharmacokinetics of co-administered drugs upon inhibition
06

Interacting drugs

Wide range of drugs and xenobiotics
07

Biomarkers

P-glycoprotein expression levelsP-glycoprotein function

Beyond the preview

Go deeper on P-glycoprotein (P-gp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on P-glycoprotein (P-gp).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call